ArticleCancer research communications2023

Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer.

Anjali Yadav et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.